Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAC-14028 cream in mild to moderate atopic dermatitis
NCT02583022Phase 2Completed
- Sponsor
- Amorepacific Corporation
- Start
- Jun 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules, Drug Delivery Systems
01
Overview
A Phase 2 trial of asivatrep in atopic dermatitis (AD), sponsored by Amorepacific Corporation. Started Jun 2013; status: completed.
02
Drugs
asivatrep
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02583022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02583022.